Swapnali Joshi

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 101 citations · Full text

Medicine, Hematology, Oncology +15

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia

Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde et al. · Oncotarget · 2018 · 36 citations · Full text

Medicine, Hematology, Oncology +17

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

Nikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe et al. · Frontiers in Oncology · 2019 · 20 citations · Full text

Medicine, Hematology, Oncology +17

Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>

Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 16 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Characteristics of<i>BCR-ABL</i>kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance

Nikhil Patkar, Kiran Ghodke, Swapnali Joshi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 15 citations

Life Sciences, Genetics, Hematology +15